The gut microbiome controls reactive astrocytosis during Aβ amyloidosis via propionate-mediated regulation of IL-17

Accumulating evidence implicates the gut microbiome (GMB) in the pathogenesis and progression of Alzheimer’s disease (AD). We recently showed that the GMB regulates reactive astrocytosis and Aβ plaque accumulation in a male APPPS1-21 AD mouse model. Yet, the mechanism(s) by which GMB perturbation al...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sidhanth Chandra, Jelena Popovic, Naveen K. Singhal, Elyse A. Watkins, Hemraj B. Dodiya, Ian Q. Weigle, Miranda A. Salvo, Abhirami Ramakrishnan, Zhangying Chen, Thomas Watson, Aashutosh Shetti, Natalie Piehl, Xiaoqiong Zhang, Leah Cuddy, Katherine R. Sadleir, Steven J. Schwulst, Murali Prakriya, David Gate, Sangram S. Sisodia, Robert Vassar
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 2025-07-01
סדרה:	The Journal of Clinical Investigation
נושאים:	Immunology Microbiology Neuroscience
גישה מקוונת:	https://doi.org/10.1172/JCI180826
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!